Research Professor of Pathology and Laboratory Medicine Yvonne Janssen-Heininger, Ph.D., an expert in the fields of pulmonary fibrosis and redox medicine, has been awarded the Lung Cancer Discovery Award by the American Lung Association in Vermont, according to Vermont Business Magazine. The grant will fund a project seeking to study protein oxidation in the development of lung cancer with the aim of creating a new druggable target for chemotherapy-resistant tumors. “The goal,” Janssen-Heininger said, “is to be able to interfere with this protein oxidation pathway, focusing on a specific target, in order to destroy lung tumors and to cause cancers to respond much better to cisplatin [chemotherapy], at lower doses. Ultimately, we hope this study will lead to improved response to immunotherapy.”

Read full story at Vermont Business Magazine